Drug Shortage Report for ZESTORETIC
Report ID | 202917 |
Drug Identification Number | 02103729 |
Brand name | ZESTORETIC |
Common or Proper name | Zestoretic 10/12.5 |
Company Name | SEARCHLIGHT PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | LISINOPRIL HYDROCHLOROTHIAZIDE |
Strength(s) | 10MG 12.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 tablets |
ATC code | C09BA |
ATC description | ACE INHIBITORS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-09-02 |
Actual start date | 2023-09-02 |
Estimated end date | 2025-05-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-12-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2024-12-05 | French | Compare |
v11 | 2024-12-05 | English | Compare |
v10 | 2024-12-05 | English | Compare |
v9 | 2023-12-05 | French | Compare |
v8 | 2023-12-05 | English | Compare |
v7 | 2023-11-28 | French | Compare |
v6 | 2023-11-28 | English | Compare |
v5 | 2023-09-05 | French | Compare |
v4 | 2023-09-05 | English | Compare |
v3 | 2023-09-03 | English | Compare |
v2 | 2023-08-24 | French | Compare |
v1 | 2023-08-24 | English | Compare |
Showing 1 to 12 of 12